Black Diamond Therapeutics Inc.

Last updated September 27, 2026
Favorite this organization

Organization details

Legal name
Black Diamond Therapeutics Inc.
Former names
Aset Therapeutics, Inc.
Ownership
Public
Status
Active
SIC code
2836 — Biological Products, (No Diagnostic Substances)
Headquarters city
Cambridge
Headquarters state / province
Massachusetts
Headquarters country
United States
Fiscal year end
December
Ticker symbol
BDTX
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001701541
EIN
81-4254660

Board of directors

Follow this board

Chief executives

Mark A. Velleca · PRESIDENT & CEO
Dates unknown

Director election results

Annual meeting of June 26, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

11 of this board's directors also sit on 36 other boards.

Network of Black Diamond Therapeutics Inc.'s board connections Nkarta Inc. Nkarta Inc. SpyGlass Pharma Inc. SpyGlass Pharma Inc. ARS Pharmaceuticals Inc. ARS Pharmaceuticals In... Acrivon Therapeutics Inc. Acrivon Therapeutics I... Acumen Pharmaceuticals Inc. Acumen Pharmaceuticals... Artiva Biotherapeutics Inc. Artiva Biotherapeutics... Bicara Therapeutics Inc. Bicara Therapeutics In... CRISPR Therapeutics AG CRISPR Therapeutics AG Climb Bio Inc. Climb Bio Inc. Evommune Inc. Evommune Inc. Freenome Inc. Freenome Inc. Hemab Therapeutics Holdings Inc. Hemab Therapeutics Hol... Jade Biosciences Inc. Jade Biosciences Inc. Janux Therapeutics Inc. Janux Therapeutics Inc... LENZ Therapeutics Inc. LENZ Therapeutics Inc. Mineralys Therapeutics Inc. Mineralys Therapeutics... Ali Behbahani Ali Behbahani Peter Kolchinsky Peter Kolchinsky Rajeev M. Shah Rajeev M. Shah Samarth Kulkarni Samarth Kulkarni Black Diamond Therapeutics...
Shared director Other board Same sector +20 more in the list below

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Sep 18, 2026 Ali Behbahani Director Grant or award +7,707 $1.93 $14,875
Sep 18, 2026 Prakash Raman Director Grant or award +6,801 $1.93 $13,126
Jun 19, 2026 Ali Behbahani Director Grant or award +8,961 $1.66 $14,875
Jun 19, 2026 Prakash Raman Director Grant or award +7,907 $1.66 $13,126
Mar 20, 2026 Ali Behbahani Director Grant or award +6,919 $2.15 $14,876
Mar 20, 2026 Prakash Raman Director Grant or award +6,105 $2.15 $13,126
Dec 12, 2025 Ali Behbahani Director Grant or award +5,208 $2.76 $14,374
Dec 12, 2025 Prakash Raman Director Grant or award +4,665 $2.76 $12,875
Sep 19, 2025 Ali Behbahani Director Grant or award +4,291 $3.35 $14,375
Sep 19, 2025 Prakash Raman Director Grant or award +3,843 $3.35 $12,874
Jun 20, 2025 Ali Behbahani Director Grant or award +6,170 $2.33 $14,376
Jun 20, 2025 Prakash Raman Director Grant or award +5,526 $2.33 $12,876
Mar 21, 2025 Ali Behbahani Director Grant or award +7,646 $1.88 $14,374
Mar 21, 2025 Prakash Raman Director Grant or award +6,848 $1.88 $12,874
Mar 19, 2025 BIOTECH GROWTH N V 10% owner Open-market sale −1,000,000 $2.07 $2,070,000

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.